Effects of diabetes, vanadium, and insulin on glycogen synthase activation in Wistar rats (Q43958481)

28 November 2017

Effects of diabetes, vanadium, and insulin on glycogen synthase activation in Wistar rats (English)

1 reference

28 November 2017

2

1 reference

28 November 2017

Sabina Semiz

1

1 reference

PubMed ID

11952162

28 November 2017

John H McNeill

series ordinal

3

1 reference

28 November 2017

1 February 2002

1 reference

Molecular and Cellular Biochemistry

28 November 2017

1 reference

28 November 2017

231

1 reference

28 November 2017

23-35

1 reference

28 November 2017

1-2

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1014437019586

28 November 2017

0 references

cites work

Signal transduction: Life, the universe and ... development

1 reference

12 December 2020

Multisite phosphorylation of glycogen synthase from rabbit skeletal muscle. Phosphorylation of site 5 by glycogen synthase kinase-5 (casein kinase-II) is a prerequisite for phosphorylation of sites 3 by glycogen synthase kinase-3

1 reference

12 December 2020

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

12 December 2020

Insulin receptor function and glycogen synthase activity in skeletal muscle biopsies from patients with insulin-dependent diabetes mellitus: effects of physical training

1 reference

12 December 2020

Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Phosphorylation of sites 3a and 3b (Ser640 and Ser644) in the control of rabbit muscle glycogen synthase

1 reference

12 December 2020

Insulin activates protein kinase B, inhibits glycogen synthase kinase-3 and activates glycogen synthase by rapamycin-insensitive pathways in skeletal muscle and adipose tissue

1 reference

12 December 2020

Inhibition of glycogen synthase kinase-3 by insulin in cultured human skeletal muscle myoblasts

1 reference

12 December 2020

Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies

1 reference

12 December 2020

Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats

1 reference

12 December 2020

Protein Phosphatase-1 and -2A Activities in Heart, Liver, and Skeletal Muscle Extracts from Control and Diabetic Rats

1 reference

12 December 2020

In vivo effects of insulin and bis(maltolato)oxovanadium (IV) on PKB activity in the skeletal muscle and liver of diabetic rats

1 reference

12 December 2020

Glycogen synthase from rabbit skeletal muscle; effect of insulin on the state of phosphorylation of the seven phosphoserine residues in vivo

1 reference

12 December 2020

The α-isoform of glycogen synthase kinase-3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase-activated protein kinase-1 in vitro

1 reference

12 December 2020

Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle

1 reference

12 December 2020

13C/31P NMR studies on the mechanism of insulin resistance in obesity

1 reference

12 December 2020

Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV)

1 reference

12 December 2020

Mitogen-activated S6 kinase is stimulated via protein kinase C-dependent and independent pathways in Swiss 3T3 cells

1 reference

12 December 2020

Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin-resistant patients with non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice

1 reference

12 December 2020

Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes

1 reference

12 December 2020

General characteristics of the insulin resistance syndrome: prevalence and heritability. European Group for the study of Insulin Resistance (EGIR).

1 reference

12 December 2020

Protein phosphatase-1 and insulin action.

1 reference

12 December 2020

An insulin-stimulated ribosomal protein S6 kinase from rabbit liver

1 reference

12 December 2020

Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies

1 reference

12 December 2020

An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues

1 reference

12 December 2020

Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action

1 reference

12 December 2020

In vivo regulation of protein-serine kinases by insulin in skeletal muscle of fructose-hypertensive rats

1 reference

12 December 2020

The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle

1 reference

12 December 2020

Vanadate restores glucose 6-phosphate in diabetic rats: a mechanism to enhance glucose metabolism

1 reference

12 December 2020

Oral treatment with vanadium of Zucker fatty rats activates muscle glycogen synthesis and insulin-stimulated protein phosphatase-1 activity

1 reference

12 December 2020

Glucose transport and NIDDM

1 reference

12 December 2020

Activation of glycogen synthase in rat adipocytes by insulin and glucose involves increased glucose transport and phosphorylation

1 reference

12 December 2020

A specific immunoprecipitation assay for the protein kinase FA/glycogen synthase kinase 3

1 reference

12 December 2020

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

1 reference

12 December 2020

Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase

1 reference

12 December 2020

Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B.

1 reference

12 December 2020

Acute and chronic oral administration of bis(maltolato)oxovanadium(IV) in Zucker diabetic fatty (ZDF) rats

1 reference

12 December 2020

The molecular mechanism by which adrenalin inhibits glycogen synthesis

1 reference

12 December 2020

Insulin-mediated effect on the activity of UDPG-glycogen transglucosylase of muscle

1 reference

12 December 2020

Expression of glycogen synthase and phosphofructokinase in muscle from type 1 (insulin-dependent) diabetic patients before and after intensive insulin treatment.

1 reference

12 December 2020

Glycogen synthase: activation by insulin and effect of transgenic overexpression in skeletal muscle

1 reference

12 December 2020

Molecular cloning and expression of glycogen synthase kinase-3/factor A

1 reference

12 December 2020

Insulin-mediated glycogen synthase activity in muscle of spontaneously insulin-resistant and diabetic rhesus monkeys

1 reference

12 December 2020

Characterization of insulin-stimulated seryl/threonyl protein kinases in rat skeletal muscle

1 reference

12 December 2020

Natural course of insulin resistance in type I diabetes.

1 reference

12 December 2020

Distinct glucose lowering and beta cell protective effects of vanadium and food restriction in streptozotocin-diabetes

1 reference

12 December 2020

Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes

1 reference

12 December 2020

Tyrosine dephosphorylation of glycogen synthase kinase-3 is involved in its extracellular signal-dependent inactivation

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1014437019586

1 reference

PubMed ID

11952162

Dimensions Publication ID

28 November 2017

0 references

1 reference

PubMed ID

11952162